Lag Period of Anti-Tuberculosis Drugs

1. Definition

2. Why a Lag Period Exists

3. Lag Period of Individual First-Line Anti-TB Drugs

A. Isoniazid (INH)

• Mechanism: Inhibits mycolic acid synthesis via InhA after activation by KatG (prodrug)
• Lag period: ~2–4 hours (short)
• Notes:
  • Most potent early bactericidal activity (EBA) drug — kills ~95% of log-phase bacilli within the first 2 days
  • Rapid killing begins within hours of first dose; EBA Days 0–2 is the highest of all anti-TB drugs
  • Requires KatG activation; INH-resistant strains (katG mutation) negate this
  • Sterilizing activity is poor — does not kill semi-dormant bacilli effectively

B. Rifampicin (Rifampin, RIF)

• Mechanism: Inhibits DNA-dependent RNA polymerase (rpoB gene product)
• Lag period: ~2–4 hours
• Notes:
  • Also demonstrates high early bactericidal activity but slightly slower than INH in EBA Days 0–2
  • Has superior sterilizing activity among all first-line drugs — kills semi-dormant and "persister" bacilli
  • High lipid solubility aids penetration into granulomas and caseous foci
  • Lag period is short due to rapid distribution; rifampicin's half-life ~3–4 hours but tissue penetration is excellent

C. Pyrazinamide (PZA)

• Mechanism: Converted to pyrazinoic acid by mycobacterial pyrazinamidase (pncA gene); disrupts membrane potential and energy metabolism in acidic environments
• Lag period: ~2–7 days (longest among first-line drugs)
• Notes:
  • PZA has no significant EBA in Days 0–2 despite first-dose administration
  • Activity is uniquely pH-dependent — only effective at pH <6 (within macrophage phagolysosomes, caseous lesions)
  • The extended lag reflects the time needed for bacilli to be in an acidic microenvironment and for sufficient pyrazinoic acid accumulation
  • Clinically crucial in the sterilizing phase (continuation phase) — shortens treatment from 9–12 months to 6 months
  • EBA becomes apparent only after Day 3–7

D. Ethambutol (EMB)

• Mechanism: Inhibits arabinosyl transferase (embB gene), blocking arabinogalactan synthesis in the mycobacterial cell wall
• Lag period: ~4–6 hours
• Notes:
  • Bacteriostatic rather than bactericidal at standard doses
  • EBA is modest (much lower than INH or RIF)
  • Primarily used to prevent emergence of resistance during the intensive phase
  • Lag period reflects absorption + cell wall penetration

4. Early Bactericidal Activity (EBA) — Clinical Measurement of Lag Period

EBA = log₁₀ CFU/mL/day reduction in sputum bacillary load

5. Second-Line Drug Lag Periods

6. Factors That Prolong the Lag Period

1. Drug resistance (genetic mutations at drug targets)
2. Low drug bioavailability — food interactions (rifampicin best absorbed fasting)
3. High bacterial burden — more bacilli require longer killing time
4. Dormancy/phenotypic tolerance — non-replicating persister bacilli are inherently slower to kill
5. Caseous necrosis — poor drug penetration into avascular necrotic tissue
6. Immunosuppression — HIV co-infection, malnutrition reduce host-drug synergy
7. Pharmacogenomics — slow vs. rapid acetylators of INH (NAT2 polymorphism)

7. Clinical Significance of the Lag Period

8. Summary Table